scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PNAS..108.7113M |
P356 | DOI | 10.1073/PNAS.1104097108 |
P932 | PMC publication ID | 3084121 |
P698 | PubMed publication ID | 21482754 |
P5875 | ResearchGate publication ID | 51041549 |
P50 | author | Bruce William Stillman | Q991815 |
Johannes Zuber | Q47713758 | ||
Katherine McJunkin | Q57322058 | ||
P2093 | author name string | Scott W. Lowe | |
Anthony Mazurek | |||
Janelle Simon | |||
Lukas E. Dow | |||
Prem K. Premsrirut | |||
P2860 | cites work | Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth | Q24305583 |
Single copy shRNA configuration for ubiquitous gene knockdown in mice | Q24797255 | ||
Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes | Q27860662 | ||
Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells | Q28143506 | ||
Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism | Q28245231 | ||
Physical and functional interaction between Pes1 and Bop1 in mammalian ribosome biogenesis | Q28269244 | ||
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors | Q28275174 | ||
Transcriptional activation by tetracyclines in mammalian cells | Q28303934 | ||
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry | Q28509466 | ||
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference | Q29615920 | ||
Design of a genome-wide siRNA library using an artificial neural network | Q33219720 | ||
Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses | Q33235763 | ||
Reconstitution of RPA-covered single-stranded DNA-activated ATR-Chk1 signaling | Q33628411 | ||
Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells | Q33930407 | ||
A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells | Q33938488 | ||
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues | Q34417194 | ||
Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice | Q34745859 | ||
Functional identification of optimized RNAi triggers using a massively parallel sensor assay | Q35088838 | ||
A rapid and scalable system for studying gene function in mice using conditional RNA interference | Q35627849 | ||
Reversible gene knockdown in mice using a tight, inducible shRNA expression system | Q35804666 | ||
Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi | Q36088050 | ||
Tissue-specific and reversible RNA interference in transgenic mice | Q36129232 | ||
Vagaries of conditional gene targeting | Q36853628 | ||
Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells | Q39874162 | ||
Conditional gene silencing in mammalian cells mediated by a stress-inducible promoter | Q40049737 | ||
Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness | Q40537918 | ||
Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity | Q40785247 | ||
High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly. | Q41919230 | ||
Germline transmission of RNAi in mice | Q44283786 | ||
Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells | Q46885318 | ||
Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. | Q55060937 | ||
Diphtheria toxin receptor–mediated conditional and targeted cell ablation in transgenic mice | Q60017797 | ||
Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene | Q69344366 | ||
Methods for studying pro- and antiapoptotic genes in nonimmortal cells | Q73983320 | ||
P4510 | describes a project that uses | RNA interference | Q201993 |
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | RNA interference | Q201993 |
Replication protein A3 | Q21990542 | ||
P304 | page(s) | 7113–7118 | |
P577 | publication date | 2011-04-26 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Reversible suppression of an essential gene in adult mice using transgenic RNA interference | |
P478 | volume | 108 |
Q33793854 | A Pipeline for Drug Target Identification and Validation |
Q60931333 | A Tet/Q Hybrid System for Robust and Versatile Control of Transgene Expression in C. elegans |
Q37488746 | A modular and flexible ESC-based mouse model of pancreatic cancer. |
Q35040636 | A novel piggyBac transposon inducible expression system identifies a role for AKT signalling in primordial germ cell migration |
Q37047996 | A pipeline for the generation of shRNA transgenic mice |
Q33907381 | Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5. |
Q35050602 | An RNAi-based approach to down-regulate a gene family in vivo |
Q35237394 | An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance |
Q34701068 | Bioinformatics analysis identify novel OB fold protein coding genes in C. elegans |
Q92849835 | CRISPR/Cas9-targeted mutagenesis of Os8N3 in rice to confer resistance to Xanthomonas oryzae pv. oryzae |
Q38084235 | Cancer of mice and men: old twists and new tails |
Q35798798 | Direct and indirect targeting of MYC to treat acute myeloid leukemia |
Q38876767 | Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains |
Q36512514 | Embedding siRNA sequences targeting apolipoprotein B100 in shRNA and miRNA scaffolds results in differential processing and in vivo efficacy |
Q38061354 | Functional genomic screening to enhance oncolytic virotherapy |
Q38680916 | Genetic compensation: A phenomenon in search of mechanisms. |
Q34039768 | Genetically engineered mouse models for drug development and preclinical trials |
Q36673042 | Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia |
Q52430693 | Inducible Genome Editing with Conditional CRISPR/Cas9 Mice. |
Q34522818 | Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibition |
Q37550614 | Loss-of-function genetic tools for animal models: cross-species and cross-platform differences |
Q37745422 | Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase |
Q26826949 | Modeling the study of DNA damage responses in mice |
Q30434696 | Neuron-specific Sumo1-3 knockdown in mice impairs episodic and fear memories |
Q34593483 | RNA interference library research progress and its application in cancer research |
Q34033373 | RNAi screening: new approaches, understandings, and organisms |
Q54377682 | RNAi-mediated knockdown of IKK1 in transgenic mice using a transgenic construct containing the human H1 promoter. |
Q37661378 | Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization |
Q37591111 | Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells |
Q24321623 | Splicing factor SRSF6 promotes hyperplasia of sensitized skin |
Q38173633 | Stable RNA interference rules for silencing |
Q35941539 | Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis |
Q21092858 | The mouse genetics toolkit: revealing function and mechanism |
Q37256287 | Tumor cell survival dependence on the DHX9 DExH-box helicase |